Financial Gravity Asset Management, Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
Financial Gravity Asset Management, Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$3,144,000
+930.8%
21
+425.0%
0.06%
+6300.0%
Q1 2020$305,000
+193.3%
4
-55.6%
0.00%
-98.6%
Q4 2019$104,000
+10300.0%
90.0%0.07%
+7100.0%
Q3 2019$1,0000.0%90.0%0.00%0.0%
Q2 2019$1,000
-98.0%
9
-97.8%
0.00%
-97.6%
Q1 2019$51,000
+54.5%
408
+105.0%
0.04%
+17.1%
Q3 2018$33,000
+1550.0%
199
+1890.0%
0.04%
+1650.0%
Q2 2018$2,000
+100.0%
10
+42.9%
0.00%
+100.0%
Q1 2018$1,00070.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders